DailyIQ
|
Sector:Real EstateAll sectors
Last updated 4 minutes ago

DOC·Healthpeak Properties, Inc.

$.
+. (+.%)
After Hours
High
$21.79
Open
$21.71
Market Cap
15.29B
52W High
$22.12
Low
$21.30
P. Close
$21.65
P/E
68.84
52W Low
$15.70
Fwd P/E
657.62
DailyIQ Est.
$22.26
Technical Score (1D)
82
BUY
News Sentiment
49
MIXED
Healthpeak’s most recent announcement is a declaration of a monthly cash dividend of $0.10167 per share for Q3 2026, underscoring the REIT’s steady cash flow and likely attracting income‑focused investors in the next few trading days. The dividend declaration may trigger short‑term buying as investors adjust for the upcoming payment dates, so watch the record date and payment schedule for timing effects. A few hours earlier, UBS lifted its price target for DOC to $21.50 from $19 while keeping a Neutral rating, signaling modest upside potential that could influence valuation expectations in the near term. UBS’s upgrade reflects confidence in Healthpeak’s portfolio performance, so monitor the next earnings release to see if guidance aligns with the new target. Barclays has also initiated coverage with an equal‑weight recommendation and a $23 price target, adding a neutral benchmark that may affect short‑term sentiment as the market digests the new rating. The convergence of UBS and Barclays viewpoints points to a broadly neutral outlook, so keep an eye on any subsequent rating revisions that could shift sentiment. Mizuho Securities has raised its target to $24 and upgraded to Outperform, reflecting optimism about earnings and dividend prospects, which could reinforce the upward bias in the next few days. The cumulative effect of multiple upgrades may lead to a reassessment of DOC’s valuation, so watch for any changes in the dividend policy or lease renewal cycles that could validate or undermine the new targets. Finally, the 28% rally over the past three months, driven by strong leasing activity and Janus Living expansion, provides a longer‑term backdrop; monitor lease renewal dates and Janus Living growth to gauge sustained momentum.
Earnings Summary
Healthpeak Properties, Inc. (DOC) is a U.S. real‑estate investment trust that focuses on healthcare facilities, owning and operating outpatient medical, laboratory, and continuing‑care retirement community properties across a geographically diverse portfolio of 703 assets. The REIT operates through its subsidiary Healthpeak OP and maintains joint‑venture interests that broaden its exposure within the healthcare real‑estate sector. In the most recent two quarters, DOC reported a sharp turnaround: Q3 2025 saw a negative EPS of –$0.1819 against an estimate of $0.06, while Q4 2025 produced a robust EPS of $0.47 versus an estimate of $0.0572, marking a 3‑quarter streak of earnings beats. Revenue rose from $678.5 million in Q2 2025 to $690.3 million in Q3 2025 and then to $719.4 million in Q4 2025, reflecting a year‑over‑year increase of roughly 5.6% from Q4 2024’s $681.1 million and a continued upward trajectory in the fourth‑quarter cycle. Historically, DOC has shown a pattern of revenue growth even when earnings have been volatile; the jump in Q4 2025 EPS from the modest $0.0508 in Q4 2024 to $0.47 underscores a significant earnings acceleration that aligns with the REIT’s focus on high‑barrier lab and outpatient leasing. Recent analyst commentary, including Mizuho Securities’ upgrade to overweight and a $24 target price, highlights confidence in DOC’s operational improvements and dividend policy, while JP Morgan’s neutral rating lift to $21 reflects optimism about the company’s portfolio stability and earnings outlook. Investors should watch for lease renewal data and occupancy trends in the next earnings cycle, as early renewals could cement the current upside; key will be commentary on debt‑management strategy and cash‑flow sustainability, which will influence the REIT’s ability to maintain its dividend payout in a tightening interest‑rate environment.}}

EPS

EstBeatMiss
$-0.28$-0.07$0.14$0.36$0.57Q4'24Q1'25Q2'25Q3'25Q4'25Q2'26
QtrEstActual+/−
Q2'26$0.03 - -
Q4'25$0.06$0.47+721.7%
Q3'25$0.06$-0.18-403.2%
Q2'25$0.06$0.06+12.2%
Q1'25$0.04$0.06+40.7%
Q4'24$0.05$0.05-4.7%

Revenue

EstBeatMiss
$671M$687M$703M$719M$734MQ4'24Q1'25Q2'25Q3'25Q4'25Q2'26
QtrEstActual+/−
Q2'26$727M - -
Q4'25$698M$719M+3.0%
Q3'25 - $690M -
Q2'25 - $679M -
Q1'25 - $687M -
Q4'24 - $681M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

DOC Stock Snapshot

DOC is currently trading at $21.60, giving Healthpeak Properties, Inc. a market cap of 15.29B and a P/E ratio of 68.8. Today's range spans $21.30–$21.79, with shares opening at $21.71 and moving down $0.05 (0.2%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 49/100.

Over the past year DOC has traded between $15.70 and $22.12 - the current price is +37.6% off the 52-week low and -2.4% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $21.82 (range $17.00–$29.00), implying upside of +1.0%.

Algorithmic and quant fund activity in DOC tends to intensify when the technical score crosses the 82/100 threshold - systematic models in large-cap Real Estate names trigger entry signals at these levels, adding momentum to what may have started as fundamental-driven buying. Signal: BUY. Sentiment: neutral (49/100). Price: $21.60 (near 52-week highs). The current P/E ratio stands at 68.8. Annual range: $15.70–$22.12.

The combination of a BUY signal (82/100) and neutral news sentiment (49/100) puts DOC on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 15.29B in Real Estate market cap without immediately moving the stock. At $21.60 (near 52-week highs in the $15.70–$22.12 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.